Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -11.11x is 11% below its 3-year average of -10.01x, around the middle of its 3-year range (-18.38x–-3.57x).
80.49% below its 12-month average of -6.16x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2026 (2026-06-30): -4.17x.
INTEREST COVERAGE RATIO
-11.11x
INTEREST COVERAGE RATIO AVG TTM
-6.16x
INTEREST COVERAGE RATIO AVG 3Y
-10.01x
INTEREST COVERAGE RATIO AVG 5Y
-10.01x
INTEREST COVERAGE RATIO AVG 10Y
-8.17x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-80.49%
CURRENT VS 3Y AVG
-11.03%
CURRENT VS 5Y AVG
-11.03%
CURRENT VS 10Y AVG
-35.93%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.42x
median of 428 covered companies
CURRENT VS SECTOR MEDIAN
-104.98%
vs the sector median at left
Enanta Pharmaceuticals, Inc.
Market Cap
$357.23M
Interest Coverage Ratio
-11.11x
TTM Avg
-6.16x
3Y Avg
-10.01x
5Y Avg
-10.01x
Market Cap
$359.46M
Interest Coverage Ratio
-12.13x
TTM Avg
372.18x
3Y Avg
320.22x
5Y Avg
320.22x
Market Cap
$358.83M
Interest Coverage Ratio
-3.05x
TTM Avg
0.61x
3Y Avg
0.61x
5Y Avg
0.61x
Market Cap
$353.30M
Interest Coverage Ratio
-45.13x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$354.19M
Interest Coverage Ratio
3.07x
TTM Avg
2.31x
3Y Avg
3.74x
5Y Avg
3.74x
Market Cap
$353.21M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$363.23M
Interest Coverage Ratio
-26.33x
TTM Avg
2025.11x
3Y Avg
2025.11x
5Y Avg
2025.11x
Market Cap
$340.01M
Interest Coverage Ratio
-0.37x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.39x
Market Cap
$374.16M
Interest Coverage Ratio
-1.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enanta Pharmaceuticals, Inc. (ENTA) | $357.23M | -11.11x | -6.16x | -10.01x | -10.01x |
| Ocugen, Inc. (OCGN)vs › | $359.46M | -12.13x | 372.18x | 320.22x | 320.22x |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $358.83M | -3.05x | 0.61x | 0.61x | 0.61x |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $353.30M | -45.13x | N/A | N/A | N/A |
| Embecta Corp. (EMBC)vs › | $354.19M | 3.07x | 2.31x | 3.74x | 3.74x |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $353.21M | N/A | N/A | N/A | N/A |
| Opus Genetics, Inc. (IRD)vs › | $363.23M | -26.33x | 2025.11x | 2025.11x | 2025.11x |
| Agenus Inc. (AGEN)vs › | $340.01M | -0.37x | 0.39x | 0.39x | 0.39x |
| Canopy Growth Corporation (CGC)vs › | $374.16M | -1.91x | N/A | N/A | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $334.95M | -10.12x | N/A | N/A | N/A |
Interest Coverage
-11.1x
Debt/Equity
0.55
Current Ratio
3.76
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -4.17x |
| 2026-03-31 | -3.57x |
| 2025-12-31 | -3.65x |
| 2025-09-30 | -7.70x |
| 2025-06-30 | -11.68x |
| 2025-03-31 | -14.31x |
| 2024-12-31 | -12.00x |
| 2024-09-30 | -11.57x |
| 2024-06-30 | -10.27x |
| 2024-03-31 | -12.78x |
| 2023-12-31 | -10.14x |
| 2023-09-30 | -9.85x |
| 2023-06-30 | -18.38x |
| 2018-03-31 | 15.65x |
| 2017-12-31 | 1597.44x |
| 2017-09-30 | 6032.78x |
| 2017-06-30 | -1193.55x |
| 2017-03-31 | -1188.25x |
| 2016-12-31 | -587.17x |
| 2016-09-30 | -281.73x |
| 2016-06-30 | -99.00x |
| 2016-03-31 | -51.36x |
| 2015-12-31 | 2966.17x |
| 2015-09-30 | 1837.00x |
| 2015-06-30 | 851.50x |
| 2015-03-31 | 24280.50x |
| 2014-12-31 | 35105.00x |
| 2014-09-30 | -1331.50x |
| 2014-06-30 | 6979.00x |
| 2014-03-31 | -1281.75x |
| 2013-12-31 | -1091.40x |
| 2013-09-30 | -587.63x |
| 2013-06-30 | -596.86x |
| 2013-03-31 | -444.56x |
| 2012-12-31 | 3129.86x |
